Orientations
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness
Auteurs
Langues
- Espagnol
Année de publication
2021
Type
Orientations
Catégories
- Gestion de programme
Maladies
- COVID-19
- SRAS
Mots-clés
- Planification, budgétisation et financement
